Organ Transplantation Market Report, Analysis, Opportunities by 2031
The Organ Transplantation Market is expected to register a CAGR of 9.7% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The Organ Transplantation Market report covers analysis by Type Of Organ (Heart, Kidney, Others); Products (Organ Preservation Solutions, Transplant Diagnostics, Tissue Products); Type Of Transplant (Autograft, Allograft, Others); Treatment (Analgesic, Immunosuppressant, Other); and End Users (Hospitals, Transplant Centers, Other). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Organ Transplantation Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Organ Transplantation Market Segmentation
Type Of Organ- Heart
- Kidney
- Organ Preservation Solutions
- Transplant Diagnostics
- Tissue Products
- Autograft
- Allograft
- Analgesic
- Immunosuppressant
- Other
- Analgesic
- Immunosuppressant
- Other
Strategic Insights
Organ Transplantation Market Growth Drivers- Rising Demand for Organ Transplantation Due to Chronic Diseases: Rising requirement for treatment due to more prevalence of chronic disorders, including renal failure and other diseases such as liver ailment and heart problems, leads to organ transplantation, and growing market size. The demand for replacing therapies with an organic element is rising globally, and therefore, the demand for that kind of treatment has grown significantly, impacting a considerable growth in both share and market size during the forecast period.
- Innovations in Organ Preservation and Transplantation: Industry innovations in organ preservation techniques and transplantation continue to expand the market. Improvements in the form of ex vivo organ perfusion and advanced storage solutions enhance the feasibility of organs as well as the success rate of their transplantation. Such improvements expand Organ Transplantation Market size, attract key players, and lead to market share gains and the wide adoption of the new technology across the global Organ Transplantation Market, as determined by market research report analysis.
- Government Policies and Public Awareness Drive Market Growth: Government policies and public campaign initiatives about organ donation are among the key factors that drive growth in the organ transplantation market. Market overviews describe the fact that policy directives such as public awareness, compensation to the donors, and favorable regulations towards organ donation increase market share. The research conducted for the market is in this context; the legislature campaigns and the facilitation of health organizations collaborating in this regard are described as market reports. This reflects the fact that increased accessibility of organs leads to improved patient outcomes and hence Organ Transplantation Market growth.
- 3D Bioprinting and Regenerative Medicine: 3D bioprinting and regenerative medicine are the upcoming trends in the organ transplantation market, and it has been an innovative solution for the growth of organs and tissues. Key market dynamics have indicated their interest in the further development of this technology to not depend on donors anymore. SWOT analysis highlights the opportunities along with the challenges that can be carried out with the prospects related to scalability. The Organ Transplantation Market forecast reflects the long-term potential of 3D bioprinting to revolutionize transplantation. PEST analysis showcases favorable regulatory environments and technological advancements supporting further Organ Transplantation Market growth.
- Xenotransplantation:This new trend of using animal organs for human transplants refers to a xenotransplantation-an emerging market trend that has captured market interest in the light of organ shortages. Key players are investing heavily in this area, using gene editing technologies to address immune rejection. Market strategies reflect a push to bring xenotransplantation into mainstream medical practice, as indicated in the market dynamics this trend holds transformative potential, with market forecasts pointing towards long-term impact. PEST analysis underscores regulatory and ethical considerations for the adoption of this technology.
- Advances in Organ Preservation and Transportation Boost Success Rates: Advances in the preservation and transportation of organs enhance the success rate of transplants. Major market players are interested in more efficient transport solutions such as portable perfusion systems. PEST analysis reflects how regulatory bodies encourage the development of technologies that extend organ viability and, therefore increase the market dynamics. Important opportunities are evident in SWOT analysis for positive market forecasts; thus advancing organ availability makes it a critical factor in Organ Transplantation Market expansion.
- Growth Prospects in Asia-Pacific for Organ Transplantation Services: Growth prospects for the organ transplantation service industry are enormous, particularly in Asia-Pacific regions, owing to increased healthcare investments and awareness about organ donation. Competitive positioning "As per competitive analysis, key players can appropriate market share by localizing education campaigns and improving infrastructure. Favorable geography-specific market dynamics, such as changes in regulations that promote transplants, provide promising opportunities. This opportunity supports the industry landscape expansion, as new growth avenues have emerged with the increase in demand for transplantation services.
- Innovation in Immunosuppressive Drugs Enhances Transplant Success: The growth opportunity for the organ transplantation market comes from the betterment of immunosuppressive drugs to prevent transplant organ rejection. Key players are focused on therapies that minimize adverse side effects and increase transplant success rates. This competitive analysis presents sharp interest in North America where the innovation factor related to immunosuppressive treatment has been robust. Moreover, it corresponds with growth based on Organ Transplantation Market dynamics of high demand for effective, personalized therapies that strengthen the overall industry landscape and drive further market expansion globally.
- Public-Private Partnerships Fuel Organ Transplantation Market Growth: Different public institutions, private companies, and non-profits are coming together with each other to fuel market growth in the organ transplantation market. The competitive analysis is such that it causes an influx of innovation, improves donation rates, and gets patients to get transplants. North America and Europe are applying geography-specific strategies here, which help in growing the industry landscape. How public-private partnerships can pool together resources and expertise helps to streamline organ donation systems, expand reach, and handle key market dynamics effectively.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Organ Transplantation Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Organ Transplantation Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Organ Transplantation Market is estimated to witness a CAGR of 9.5% from 2023 to 2031.
The major factors driving the Organ Transplantation Market are: Increasing Prevalence of Chronic Diseases, Technological Advancements in Organ Preservation, and Supportive Government Initiatives and Organ Donation Campaigns
Key future trends in this market are - Adoption of 3D Bioprinting and Regenerative Medicine, Focus on Xenotransplantation, and Expansion of Organ Preservation and Transport Technologies
Key companies in this market are: Transonic, F Hoffmann La Roche Ltd, Astellas Pharma Inc, Preservation Solutions Inc, OrganOX Limited, TransMedic Inc, Accord Healthcare GmbH, Sanofi, Pfizer Inc.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Organ Transplantation Market - By Type of Organ
1.3.2 Organ Transplantation Market - By Products
1.3.3 Organ Transplantation Market - By Type of Transplant
1.3.4 Organ Transplantation Market - By Treatment
1.3.5 Organ Transplantation Market - By End Users
1.3.6 Organ Transplantation Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ORGAN TRANSPLANTATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ORGAN TRANSPLANTATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ORGAN TRANSPLANTATION MARKET - GLOBAL MARKET ANALYSIS
6.1. ORGAN TRANSPLANTATION - GLOBAL MARKET OVERVIEW
6.2. ORGAN TRANSPLANTATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ORGAN TRANSPLANTATION MARKET - REVENUE AND FORECASTS TO 2028 - TYPE OF ORGAN
7.1. OVERVIEW
7.2. TYPE OF ORGAN MARKET FORECASTS AND ANALYSIS
7.3. HEART
7.3.1. Overview
7.3.2. Heart Market Forecast and Analysis
7.4. KIDNEY
7.4.1. Overview
7.4.2. Kidney Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. ORGAN TRANSPLANTATION MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCTS
8.1. OVERVIEW
8.2. PRODUCTS MARKET FORECASTS AND ANALYSIS
8.3. ORGAN PRESERVATION SOLUTIONS
8.3.1. Overview
8.3.2. Organ Preservation Solutions Market Forecast and Analysis
8.4. TRANSPLANT DIAGNOSTICS
8.4.1. Overview
8.4.2. Transplant Diagnostics Market Forecast and Analysis
8.5. TISSUE PRODUCTS
8.5.1. Overview
8.5.2. Tissue Products Market Forecast and Analysis
9. ORGAN TRANSPLANTATION MARKET - REVENUE AND FORECASTS TO 2028 - TYPE OF TRANSPLANT
9.1. OVERVIEW
9.2. TYPE OF TRANSPLANT MARKET FORECASTS AND ANALYSIS
9.3. AUTOGRAFT
9.3.1. Overview
9.3.2. Autograft Market Forecast and Analysis
9.4. ALLOGRAFT
9.4.1. Overview
9.4.2. Allograft Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. ORGAN TRANSPLANTATION MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
10.1. OVERVIEW
10.2. TREATMENT MARKET FORECASTS AND ANALYSIS
10.3. ANALGESIC
10.3.1. Overview
10.3.2. Analgesic Market Forecast and Analysis
10.4. IMMUNOSUPPRESSANT
10.4.1. Overview
10.4.2. Immunosuppressant Market Forecast and Analysis
10.5. OTHER
10.5.1. Overview
10.5.2. Other Market Forecast and Analysis
11. ORGAN TRANSPLANTATION MARKET - REVENUE AND FORECASTS TO 2028 - END USERS
11.1. OVERVIEW
11.2. END USERS MARKET FORECASTS AND ANALYSIS
11.3. HOSPITALS
11.3.1. Overview
11.3.2. Hospitals Market Forecast and Analysis
11.4. TRANSPLANT CENTERS
11.4.1. Overview
11.4.2. Transplant Centers Market Forecast and Analysis
11.5. OTHER
11.5.1. Overview
11.5.2. Other Market Forecast and Analysis
12. ORGAN TRANSPLANTATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Organ Transplantation Market Overview
12.1.2 North America Organ Transplantation Market Forecasts and Analysis
12.1.3 North America Organ Transplantation Market Forecasts and Analysis - By Type Of Organ
12.1.4 North America Organ Transplantation Market Forecasts and Analysis - By Products
12.1.5 North America Organ Transplantation Market Forecasts and Analysis - By Type Of Transplant
12.1.6 North America Organ Transplantation Market Forecasts and Analysis - By Treatment
12.1.7 North America Organ Transplantation Market Forecasts and Analysis - By End Users
12.1.8 North America Organ Transplantation Market Forecasts and Analysis - By Countries
12.1.8.1 United States Organ Transplantation Market
12.1.8.1.1 United States Organ Transplantation Market by Type Of Organ
12.1.8.1.2 United States Organ Transplantation Market by Products
12.1.8.1.3 United States Organ Transplantation Market by Type Of Transplant
12.1.8.1.4 United States Organ Transplantation Market by Treatment
12.1.8.1.5 United States Organ Transplantation Market by End Users
12.1.8.2 Canada Organ Transplantation Market
12.1.8.2.1 Canada Organ Transplantation Market by Type Of Organ
12.1.8.2.2 Canada Organ Transplantation Market by Products
12.1.8.2.3 Canada Organ Transplantation Market by Type Of Transplant
12.1.8.2.4 Canada Organ Transplantation Market by Treatment
12.1.8.2.5 Canada Organ Transplantation Market by End Users
12.1.8.3 Mexico Organ Transplantation Market
12.1.8.3.1 Mexico Organ Transplantation Market by Type Of Organ
12.1.8.3.2 Mexico Organ Transplantation Market by Products
12.1.8.3.3 Mexico Organ Transplantation Market by Type Of Transplant
12.1.8.3.4 Mexico Organ Transplantation Market by Treatment
12.1.8.3.5 Mexico Organ Transplantation Market by End Users
12.2. EUROPE
12.2.1 Europe Organ Transplantation Market Overview
12.2.2 Europe Organ Transplantation Market Forecasts and Analysis
12.2.3 Europe Organ Transplantation Market Forecasts and Analysis - By Type Of Organ
12.2.4 Europe Organ Transplantation Market Forecasts and Analysis - By Products
12.2.5 Europe Organ Transplantation Market Forecasts and Analysis - By Type Of Transplant
12.2.6 Europe Organ Transplantation Market Forecasts and Analysis - By Treatment
12.2.7 Europe Organ Transplantation Market Forecasts and Analysis - By End Users
12.2.8 Europe Organ Transplantation Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Organ Transplantation Market
12.2.8.1.1 Germany Organ Transplantation Market by Type Of Organ
12.2.8.1.2 Germany Organ Transplantation Market by Products
12.2.8.1.3 Germany Organ Transplantation Market by Type Of Transplant
12.2.8.1.4 Germany Organ Transplantation Market by Treatment
12.2.8.1.5 Germany Organ Transplantation Market by End Users
12.2.8.2 France Organ Transplantation Market
12.2.8.2.1 France Organ Transplantation Market by Type Of Organ
12.2.8.2.2 France Organ Transplantation Market by Products
12.2.8.2.3 France Organ Transplantation Market by Type Of Transplant
12.2.8.2.4 France Organ Transplantation Market by Treatment
12.2.8.2.5 France Organ Transplantation Market by End Users
12.2.8.3 Italy Organ Transplantation Market
12.2.8.3.1 Italy Organ Transplantation Market by Type Of Organ
12.2.8.3.2 Italy Organ Transplantation Market by Products
12.2.8.3.3 Italy Organ Transplantation Market by Type Of Transplant
12.2.8.3.4 Italy Organ Transplantation Market by Treatment
12.2.8.3.5 Italy Organ Transplantation Market by End Users
12.2.8.4 Spain Organ Transplantation Market
12.2.8.4.1 Spain Organ Transplantation Market by Type Of Organ
12.2.8.4.2 Spain Organ Transplantation Market by Products
12.2.8.4.3 Spain Organ Transplantation Market by Type Of Transplant
12.2.8.4.4 Spain Organ Transplantation Market by Treatment
12.2.8.4.5 Spain Organ Transplantation Market by End Users
12.2.8.5 United Kingdom Organ Transplantation Market
12.2.8.5.1 United Kingdom Organ Transplantation Market by Type Of Organ
12.2.8.5.2 United Kingdom Organ Transplantation Market by Products
12.2.8.5.3 United Kingdom Organ Transplantation Market by Type Of Transplant
12.2.8.5.4 United Kingdom Organ Transplantation Market by Treatment
12.2.8.5.5 United Kingdom Organ Transplantation Market by End Users
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Organ Transplantation Market Overview
12.3.2 Asia-Pacific Organ Transplantation Market Forecasts and Analysis
12.3.3 Asia-Pacific Organ Transplantation Market Forecasts and Analysis - By Type Of Organ
12.3.4 Asia-Pacific Organ Transplantation Market Forecasts and Analysis - By Products
12.3.5 Asia-Pacific Organ Transplantation Market Forecasts and Analysis - By Type Of Transplant
12.3.6 Asia-Pacific Organ Transplantation Market Forecasts and Analysis - By Treatment
12.3.7 Asia-Pacific Organ Transplantation Market Forecasts and Analysis - By End Users
12.3.8 Asia-Pacific Organ Transplantation Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Organ Transplantation Market
12.3.8.1.1 Australia Organ Transplantation Market by Type Of Organ
12.3.8.1.2 Australia Organ Transplantation Market by Products
12.3.8.1.3 Australia Organ Transplantation Market by Type Of Transplant
12.3.8.1.4 Australia Organ Transplantation Market by Treatment
12.3.8.1.5 Australia Organ Transplantation Market by End Users
12.3.8.2 China Organ Transplantation Market
12.3.8.2.1 China Organ Transplantation Market by Type Of Organ
12.3.8.2.2 China Organ Transplantation Market by Products
12.3.8.2.3 China Organ Transplantation Market by Type Of Transplant
12.3.8.2.4 China Organ Transplantation Market by Treatment
12.3.8.2.5 China Organ Transplantation Market by End Users
12.3.8.3 India Organ Transplantation Market
12.3.8.3.1 India Organ Transplantation Market by Type Of Organ
12.3.8.3.2 India Organ Transplantation Market by Products
12.3.8.3.3 India Organ Transplantation Market by Type Of Transplant
12.3.8.3.4 India Organ Transplantation Market by Treatment
12.3.8.3.5 India Organ Transplantation Market by End Users
12.3.8.4 Japan Organ Transplantation Market
12.3.8.4.1 Japan Organ Transplantation Market by Type Of Organ
12.3.8.4.2 Japan Organ Transplantation Market by Products
12.3.8.4.3 Japan Organ Transplantation Market by Type Of Transplant
12.3.8.4.4 Japan Organ Transplantation Market by Treatment
12.3.8.4.5 Japan Organ Transplantation Market by End Users
12.3.8.5 South Korea Organ Transplantation Market
12.3.8.5.1 South Korea Organ Transplantation Market by Type Of Organ
12.3.8.5.2 South Korea Organ Transplantation Market by Products
12.3.8.5.3 South Korea Organ Transplantation Market by Type Of Transplant
12.3.8.5.4 South Korea Organ Transplantation Market by Treatment
12.3.8.5.5 South Korea Organ Transplantation Market by End Users
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Organ Transplantation Market Overview
12.4.2 Middle East and Africa Organ Transplantation Market Forecasts and Analysis
12.4.3 Middle East and Africa Organ Transplantation Market Forecasts and Analysis - By Type Of Organ
12.4.4 Middle East and Africa Organ Transplantation Market Forecasts and Analysis - By Products
12.4.5 Middle East and Africa Organ Transplantation Market Forecasts and Analysis - By Type Of Transplant
12.4.6 Middle East and Africa Organ Transplantation Market Forecasts and Analysis - By Treatment
12.4.7 Middle East and Africa Organ Transplantation Market Forecasts and Analysis - By End Users
12.4.8 Middle East and Africa Organ Transplantation Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Organ Transplantation Market
12.4.8.1.1 South Africa Organ Transplantation Market by Type Of Organ
12.4.8.1.2 South Africa Organ Transplantation Market by Products
12.4.8.1.3 South Africa Organ Transplantation Market by Type Of Transplant
12.4.8.1.4 South Africa Organ Transplantation Market by Treatment
12.4.8.1.5 South Africa Organ Transplantation Market by End Users
12.4.8.2 Saudi Arabia Organ Transplantation Market
12.4.8.2.1 Saudi Arabia Organ Transplantation Market by Type Of Organ
12.4.8.2.2 Saudi Arabia Organ Transplantation Market by Products
12.4.8.2.3 Saudi Arabia Organ Transplantation Market by Type Of Transplant
12.4.8.2.4 Saudi Arabia Organ Transplantation Market by Treatment
12.4.8.2.5 Saudi Arabia Organ Transplantation Market by End Users
12.4.8.3 U.A.E Organ Transplantation Market
12.4.8.3.1 U.A.E Organ Transplantation Market by Type Of Organ
12.4.8.3.2 U.A.E Organ Transplantation Market by Products
12.4.8.3.3 U.A.E Organ Transplantation Market by Type Of Transplant
12.4.8.3.4 U.A.E Organ Transplantation Market by Treatment
12.4.8.3.5 U.A.E Organ Transplantation Market by End Users
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Organ Transplantation Market Overview
12.5.2 South and Central America Organ Transplantation Market Forecasts and Analysis
12.5.3 South and Central America Organ Transplantation Market Forecasts and Analysis - By Type Of Organ
12.5.4 South and Central America Organ Transplantation Market Forecasts and Analysis - By Products
12.5.5 South and Central America Organ Transplantation Market Forecasts and Analysis - By Type Of Transplant
12.5.6 South and Central America Organ Transplantation Market Forecasts and Analysis - By Treatment
12.5.7 South and Central America Organ Transplantation Market Forecasts and Analysis - By End Users
12.5.8 South and Central America Organ Transplantation Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Organ Transplantation Market
12.5.8.1.1 Brazil Organ Transplantation Market by Type Of Organ
12.5.8.1.2 Brazil Organ Transplantation Market by Products
12.5.8.1.3 Brazil Organ Transplantation Market by Type Of Transplant
12.5.8.1.4 Brazil Organ Transplantation Market by Treatment
12.5.8.1.5 Brazil Organ Transplantation Market by End Users
12.5.8.2 Argentina Organ Transplantation Market
12.5.8.2.1 Argentina Organ Transplantation Market by Type Of Organ
12.5.8.2.2 Argentina Organ Transplantation Market by Products
12.5.8.2.3 Argentina Organ Transplantation Market by Type Of Transplant
12.5.8.2.4 Argentina Organ Transplantation Market by Treatment
12.5.8.2.5 Argentina Organ Transplantation Market by End Users
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. ORGAN TRANSPLANTATION MARKET, KEY COMPANY PROFILES
14.1. TRANSONIC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. F. HOFFMANN-LA ROCHE LTD
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. ASTELLAS PHARMA, INC
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. PRESERVATION SOLUTIONS, INC
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. ORGANOX LIMITED
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. TRANSMEDIC, INC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. ACCORD HEALTHCARE GMBH
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. SANOFI
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. PFIZER, INC
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. GLAXOSMITHKLINE PLC.
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
1. Transonic
2. F. Hoffmann-La Roche Ltd
3. Astellas Pharma, Inc
4. Preservation Solutions, Inc
5. OrganOX Limited
6. TransMedic, Inc
7. Accord Healthcare GmbH
8. Sanofi
9. Pfizer, Inc
10. GlaxoSmithKline Plc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For